NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Wednesday, August 1st. Shareholders of record on Friday, August 31st will be paid a dividend of $0.19 per share on Tuesday, September 18th. This represents a $0.76 annualized dividend and a yield of 1.06%. The ex-dividend date is Thursday, August 30th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) issued its quarterly earnings data on Thursday, August, 9th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.01. The company earned $1.19 billion during the quarter, compared to analyst estimates of $1.23 billion. Perrigo had a net margin of 4.77% and a return on equity of 11.92%. The company's revenue for the quarter was down 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.22 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, November 8th 2018. View Earnings Estimates for Perrigo.

Perrigo issued an update on its FY18 earnings guidance on Thursday, August, 9th. The company provided earnings per share guidance of $4.75-4.95 for the period, compared to the Thomson Reuters consensus estimate of $5.21.

15 analysts have issued twelve-month price objectives for Perrigo's stock. Their predictions range from $67.00 to $117.00. On average, they expect Perrigo's share price to reach $88.0667 in the next twelve months. This suggests a possible upside of 22.5% from the stock's current price. View Analyst Price Targets for Perrigo.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Some companies that are related to Perrigo include ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Alexion Pharmaceuticals (ALXN), Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), Mylan (MYL), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Jazz Pharmaceuticals (JAZZ), Sarepta Therapeutics (SRPT), Genmab A/S (GNMSF) and Bausch Health Companies (BHC).

Perrigo's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.23%), Manning & Napier Group LLC (1.06%), Bank of Montreal Can (0.15%), Andra AP fonden (0.06%), Aperio Group LLC (0.03%) and Moon Capital Management LLC (0.03%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Andra AP fonden, Aperio Group LLC, Moon Capital Management LLC, Winslow Evans & Crocker Inc., Xact Kapitalforvaltning AB and State of Alaska Department of Revenue. Company insiders that have sold Perrigo company stock in the last year include John Wesolowski, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, Bank of Montreal Can and Nisa Investment Advisors LLC. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Svend Andersen and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $71.89.

Perrigo has a market capitalization of $9.84 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]